Background: The relationship between personality and depressed mood is not well understood. The present research sought to clarify the contributions of personality to an understanding of the development, course, and maintenance of depressed mood over time.
Methods: A large community sample [n=5591, 57% women, M age=551.01] was administered the Revised Temperament and Character Inventory [TCI-R; Cloninger, 1999]: The Temperament and Character Inventory-Revised. St. Louis, MO: Center for Psychobiology of Personality, Washington University] and a modified version of the Center for Epidemiologic Studies-Depression Scale [CES-D; Radloff, 1977]: Appl Psychol Measure 1:385-401] at Time 1 [T1] and the Center for Epidemiologic Studies-Depression Scale again 4 years later at Time 2 [T2].
Results: Whereas three of the seven personality dimensions were significantly and uniquely associated with depressed mood at T1, only harm avoidance emerged as a significant unique positive predictor of depressed mood at T2. When participants were grouped according to the level of stability versus change in depressed mood during the 4-year period, reward dependence, self-directedness , and cooperativeness were found to be significantly lower among those low in depressed mood at T1 who subsequently evidenced moderate to high levels of depressed mood at T2 when compared to those with low depressed mood on both assessment occasions. Additional analyses indicated that those who evidenced moderate to high levels of depression at T1 and T2 were distinctly higher on harm avoidance and lower on self-directedness when compared to those who had consistently low or variable levels of depressed mood across the two assessment occasions.
Conclusions: Findings from this research are discussed in terms of personality-related vulnerability and risk factors for future episodes of depressed mood.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/da.20459 | DOI Listing |
Introduction: Transgender individuals may face familial and social hostility, leading to distress that significantly affects their well-being. This study aims to understand life course challenges experienced by transgender people since childhood.
Method: Cross-sectional study, including 20 transgender people.
Br J Psychol
January 2025
School of Medicine and Psychology, The Australian National University, Canberra, Australian Capital Territory, Australia.
A common guideline for self-disclosure is that therapists should only share recovered personal experiences with clients (i.e., no longer distressing).
View Article and Find Full Text PDFJ Clin Med
December 2024
Unitat de Suport a la Recerca Terres de l'Ebre, Fundació Institut Universitari per a la Recerca al'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 43500 Tortosa, Spain.
: Multicomponent, non-pharmacological therapies are the preferred first-line treatments for fibromyalgia (FM), but little is known about them in primary care settings. Our study assessed the effectiveness of the FIBROCARE Program in improving the quality of life, functional impact, mood, and pain of people with FM. : We conducted a pragmatic, randomized controlled trial that was not blinded for both patients and the professionals delivering the treatments in the study groups.
View Article and Find Full Text PDFJ Clin Med
December 2024
Clinical Department of Gynecologic Surgery and Oncology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that affects women of reproductive age and is characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. PCOS is often associated with hormonal imbalances, metabolic dysfunction and comorbid psychiatric disorders, including eating disorders (EDs). The review identifies key hormonal factors-serotonin, leptin, insulin, ghrelin, kisspeptin and cortisol-and their roles in the pathophysiology of PCOS and associated psychiatric symptoms.
View Article and Find Full Text PDFNutrients
December 2024
Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand.
Chronic stress exposure has been widely recognized as a significant contributor to numerous central nervous system (CNS) disorders, leading to debilitating behavioral changes such as anxiety, depression, and cognitive impairments. The prolonged activation of the hypothalamic-pituitary-adrenal (HPA) axis during chronic stress disrupts the neuroendocrine balance and has detrimental effects on neuronal function and survival. () Gaertn.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!